IDYA · Ideaya Biosciences Inc
United States · RS rating 44 · As of 2026-10-14
| Price | 33.86 USD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 23 / 41 / 80 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 32 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -170.7% |
| Sales growth Q/Q | -94.8% |
| Distance from 52-week high | +20.3% |
| Market cap (USD) | $2.7B |